Barclays’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-141
| Closed | – | – | 4546 |
|
|
2025
Q1 | $0 | Sell |
141
-71
| -33% | – | ﹤0.01% | 4538 |
|
|
2024
Q4 | $1K | Sell |
212
-57,018
| -100% | -$269K | ﹤0.01% | 4336 |
|
|
2024
Q3 | $159K | Buy |
57,230
+7,178
| +14% | +$19.9K | ﹤0.01% | 3589 |
|
|
2024
Q2 | $171K | Buy |
50,052
+33,710
| +206% | +$115K | ﹤0.01% | 3128 |
|
|
2024
Q1 | $89K | Buy |
16,342
+8,760
| +116% | +$47.7K | ﹤0.01% | 3679 |
|
|
2023
Q4 | $41K | Buy |
+7,582
| New | +$41K | ﹤0.01% | 3873 |
|